February 23rd 2023
February 23rd 2023
Pembrolizumab Plus Chemotherapy Approved for Metastatic Nonsquamous NSCLC
May 11th 2017Tumor response rate and progression-free survival were the benchmarks that helped pembrolizumab (Keytruda) gain accelerated approval as first-line treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), in combination with chemotherapy.
Read More
WHO Taps Into Biosimilars for Access to Expensive Cancer Drugs in Poor Nations
May 4th 2017The World Health Organization (WHO) has announced a pilot project that will take advantage of expected savings from biosimilar medications, particularly expensive anticancer agents, to make these treatments available for low- and middle-income countries.
Read More
Report Calls for Adding Shared Decision Making to CMS' Oncology Care Model
April 25th 2017A new report published by the Urban Institute suggests that CMS’ Oncology Care Model could be substantially improved by incorporating a formal framework for shared decision making between patients and oncologists.
Read More
NPC Offers Suggestions on FDA Off-Label Promotion Draft Guidance
April 19th 2017The National Pharmaceutical Council (NPC) today published a letter outlining its thoughts on the FDA draft guidance regarding manufacturer communications about off-label uses of drugs. Today was the final day to comment on the draft before the agency begins to formulate the final version of the guidance.
Read More
Value-Based Payment Models in Oncology: Will They Help or Hinder Patient Access to New Treatments?
April 18th 2017The Deloitte Center for Health Solutions recently interviewed individuals from health plans, providers, and clinical pathway developers that are participating, supporting, or evaluating oncology payment models to understand what approaches are perceived to be working, the early results, and the potential impact on innovation.
Read More
European, American Societies Provide Guidelines for Managing COPD Exacerbations
April 16th 2017The European Respiratory Society and the American Thoracic Society have conducted a comprehensive review of evidence of managing exacerbations of chronic obstructive pulmonary disease in order to create a guideline of clinical recommendations.
Read More
Oral Chemotherapy Adherence Affected by Patient Satisfaction With Oncologist and Treatment
April 12th 2017A new study has explored factors that impact patient adherence to oral chemotherapy regimens and found that improved satisfaction with their treatment and clinician was most strongly linked to better adherence.
Read More
Conflicting Breast Cancer Screening Guidelines Lead to Varying Physician Recommendations
April 11th 2017A new study published in JAMA Internal Medicine has found that the extent to which clinicians follow breast cancer screening guidelines for patients of different ages varies by their specialty and by which set of recommendations they trust most.
Read More
Clinical Pathways Successfully Drive Physicians to Lower-Cost Regimens in Colorectal Cancer
April 7th 2017Clinical pathways can successfully be used to drive physicians to choose a less costly regimen when the efficacy and toxicity of different treatment regimens for metastatic colorectal cancer are comparable, according to a study in the Journal of Oncology Practice.
Read More
Shared Orthopedic Decision Making Resulted in Better Outcomes, Higher Patient Satisfaction
April 6th 2017Research presented at the 2017 Annual Meeting of the American Academy of Orthopaedic Surgeons indicated that informed patients who engaged in shared decision making with their clinicians had better treatment outcomes and were more satisfied with their experience.
Read More
Guideline Recommendations Purged Unnecessary Imaging in Early-Stage Breast Cancer
March 29th 2017A study published in the journal Cancer has found that the rate of advanced imaging at the time of breast cancer diagnosis reduced during the period between 2008 and 2015 in the state of Michigan.
Read More
New PARP Inhibitor, Niraparib, Approved as Maintenance Therapy for Ovarian and Other Cancers
March 28th 2017Results from the randomized NOVA trial convinced the FDA to approve niraparib (Zejula) as maintenance treatment for adult patients with recurrent epithelial ovarian, fallopian tube, or peritoneal cancer who are sensitive to platinum-based chemotherapy.
Read More
Personalized Care in Lung Cancer Is All About the Molecular Subtype
March 24th 2017At the 22nd Annual Conference of the National Comprehensive Cancer Network, held March 23-25, 2017, in Orlando, FL, Gregory J. Riely, MD, PhD, Memorial Sloan Kettering Cancer Center, spoke about the what, when, and how of biomarker testing in non-small cell lung cancer.
Read More